Assessment of Nasal Deposition and Clearance of Ketorolac Solution Administered Using the Valois Nasal Spray Device

NCT01356212 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Egalet Ltd